Exosens Imaging UK Limited
Company 10255178 · Active · incorporated 28/06/2016 · Cambridge CB22 5NE · Private Limited Company
Nature of business: 72190 - Other research and experimental development on natural sciences and engineering
Latest accounts held to 2025-12-31; total assets £476,971; net assets £-8,312,721; 13 employees.
Who controls it
- Exosens Holding Uk Limited (company, registered 15361874 in England)
ownership of shares 75 to 100 percent, voting rights 75 to 100 percent, right to appoint and remove directors · from 2026-07-15 - No individual or entity with signficant control (statement)
· from 2017-06-27, ceased 2026-07-15
Where the chain ends
Companies House shows one step. Followed to the end:
- Exosens Holding UK Limited (15361874, Active)
What else sits under the same owner
- Centronic Group Limited (09300082, Active)
- Centronic Holdings Limited (01293398, Active)
Who runs it
The officer register for this company is not yet loaded here. It is on Companies House.
Public money received
- 2 grants received (360Giving), £153,704 in total
Matched on the company number. Public contracts from Find a Tender, grants from the 360Giving publishers, and farm subsidy from the published payment data, all under the Open Government Licence.
Companies with a similar fingerprint
Nearest by our vector reading of what the company is and does. A resemblance, not a relationship.
- Semarion Ltd (11534992)
- Celerion Gb Limited (01856500)
- Hyperion Research Ltd (11053676)
- Emeren Limited (12296289)
- Gaussion Ltd (13474140)
- Emagination Ltd (NI608819)
- Olberon Limited (05480127)
- 17303722 Ltd (17303722)
Check this company on Companies House.
This page is the register read in order. The full dossier goes further: what the people behind the company are worth, the whole group valued, FCA authorisation, export and HMO licences, aircraft, personal insolvency of the controllers, any appearance in the offshore leaks, and adverse media, every figure with its source. The first one is free and comes back the same working day.